![Simone Song](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simone Song
Founder at
ORI Capital Investment Advisory Hong Kong Ltd.
Net worth: - $ as of 2026-08-30
Profile
Ms. Simone Song is a Founder & Senior Partner at ORI Capital Ltd. She is on the Board of Directors at Orchard Therapeutics (Europe) Ltd., Kymab Group Ltd. and Kymab Ltd.
Ms. Song was previously employed as an Independent Non-Executive Director by Orchard Therapeutics Plc, an Independent Director by CG Oncology, Inc., and a Managing Director by Cowen, Inc. She also served on the board at Trisalus Life Sciences, Inc. (United States).
She received her undergraduate degree from Fudan University and a graduate degree from Claremont Graduate University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CG ONCOLOGY, INC. -.--% | 2025-06-04 | 0 ( -.--% ) | - $ | 2026-08-30 |
Simone Song active positions
| Companies | Position | Start |
|---|---|---|
ORI Capital Investment Advisory Hong Kong Ltd.
 ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital invests in companies located across the globe. The firm targets companies operating in the fields of biotech with a focus on diagnostics, drug delivery, and therapeutics. It participates in early-stage transactions. | Founder | 2015-06-30 |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Director/Board Member | - |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Director/Board Member | 2017-12-21 |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Director/Board Member | 2017-01-19 |
Former positions of Simone Song
| Companies | Position | End |
|---|---|---|
| CG ONCOLOGY, INC. | Director/Board Member | 2025-11-21 |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for treatment of liver and pancreatic tumors | Director/Board Member | 2022-12-31 |
| COWEN INC. | Corporate Officer/Principal | - |
| ORCHARD THERAPEUTICS PLC | Director/Board Member | - |
Training of Simone Song
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Claremont Graduate University
 Claremont Graduate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cowen, Inc.
 Cowen, Inc. Investment Banks/BrokersFinance Provides corporate & investment banking and financial services | Finance |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for treatment of liver and pancreatic tumors | Health Technology |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
ORI Capital Investment Advisory Hong Kong Ltd.
ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital invests in companies located across the globe. The firm targets companies operating in the fields of biotech with a focus on diagnostics, drug delivery, and therapeutics. It participates in early-stage transactions. | Finance |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
- Stock Market
- Insiders
- Simone Song
